![](/img/cover-not-exists.png)
Prospective, randomised, controlled study of the efficacy of interferon alpha-2b (IFN) plus ribavirin (RIB) in patients with chronic hepatitis C (CHC) ‘non responders’ to IFN
Ricardo Moreno-OteroVolume:
36
Year:
2002
Language:
english
DOI:
10.1016/s0168-8278(02)80427-5
File:
PDF, 109 KB
english, 2002